KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Change in Account Payables (2016 - 2025)

Idexx Laboratories has reported Change in Account Payables over the past 17 years, most recently at -$3.6 million for Q4 2025.

  • Quarterly results put Change in Account Payables at -$3.6 million for Q4 2025, down 162.66% from a year ago — trailing twelve months through Dec 2025 was -$8.6 million (down 206.02% YoY), and the annual figure for FY2025 was -$8.6 million, down 206.02%.
  • Change in Account Payables for Q4 2025 was -$3.6 million at Idexx Laboratories, down from $7.1 million in the prior quarter.
  • Over the last five years, Change in Account Payables for IDXX hit a ceiling of $10.6 million in Q4 2021 and a floor of -$8.1 million in Q1 2025.
  • Median Change in Account Payables over the past 5 years was -$51500.0 (2021), compared with a mean of $682800.0.
  • Biggest five-year swings in Change in Account Payables: soared 2159.28% in 2021 and later tumbled 301.11% in 2022.
  • Idexx Laboratories' Change in Account Payables stood at $10.6 million in 2021, then plummeted by 30.19% to $7.4 million in 2022, then decreased by 15.61% to $6.2 million in 2023, then decreased by 8.06% to $5.7 million in 2024, then crashed by 162.66% to -$3.6 million in 2025.
  • The last three reported values for Change in Account Payables were -$3.6 million (Q4 2025), $7.1 million (Q3 2025), and -$4.0 million (Q2 2025) per Business Quant data.